Literature DB >> 23409929

IK induced by coxsackievirus B3 infection transiently downregulates expression of MHC class II through increasing cAMP.

Hye-Lim Park1, Yeon-Jung Kim, Ha-Na Na, Mi-Young Park, Joo-Young Kim, Cheol-Won Yun, Jae-Hwan Nam.   

Abstract

Major histocompatibility complex (MHC) class II expression is critical for the presentation of antigens in the immune response to viral infection. Consequently, some viruses regulate the MHC class II-mediated presentation of viral antigens as a mechanism of immune escape. In this study, we found that Coxsackievirus B3 (CVB3) infection transiently increased IK expression, which reduced the expression of MHC class II (I-A/I-E) on splenic B cells. Interestingly, CVB3-induced IK elevated cAMP, a downstream molecule of the G protein-coupled receptors, which inhibited MHC class II presentation on B cells. Transgenic mice expressing truncated IK showed lower expression of MHC class II on B cells than did wild-type mice after CVB3 infection. Taken together, these results imply that IK plays a role in downregulating MHC class II expression on B cells during CVB3 infection through the induction of cAMP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23409929     DOI: 10.1089/vim.2012.0054

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  3 in total

1.  IK acts as an immunoregulator of inflammatory arthritis by suppressing TH17 cell differentiation and macrophage activation.

Authors:  Hye-Lim Park; Sang-Myeong Lee; Jun-Ki Min; Su-Jin Moon; Inki Kim; Kyung-Won Kang; Sooho Park; SeulGi Choi; Ha-Na Jung; Dong-Hee Lee; Jae-Hwan Nam
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

Review 2.  Immune Evasion of Enteroviruses Under Innate Immune Monitoring.

Authors:  Ying Zhang; Jingyan Li; Qihan Li
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

3.  Therapeutic Effect of Exogenous Truncated IK Protein in Inflammatory Arthritis.

Authors:  Seulgi Choi; HyeLim Park; SeoYeon Jung; Eun-Kyung Kim; Mi-La Cho; Jun-Ki Min; Su-Jin Moon; Sang-Myeong Lee; Jang-Hee Cho; Dong-Hee Lee; Jae-Hwan Nam
Journal:  Int J Mol Sci       Date:  2017-09-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.